Noxopharm Ltd has released a press release.
September 2025 Quarterly Activities Report and Appendix 4C
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Noxopharm
- First US patent for Sofra technology platform
- Extension of Convertible Notes and Funding
- HERACLES clinical trial Update 4
- Appendix 4E Preliminary Final Report
- HERACLES clinical trial Update 3
Later from Noxopharm
- Second part of HERACLES clinical trial begins
- First dose in HERACLES clinical trial Part Two
- HERACLES clinical trial Update 5
- HERACLES clinical trial successfully completed
- December 2025 Quarterly Activities Report and Appendix 4C
Follow Noxopharm into a list and get an email when it puts out news.
Follow Noxopharm